Monthly Archives: March 2018
“Updates on HPV-Associated Head and Neck Cancer” to be April 7
Posted in News
Comments Off on “Updates on HPV-Associated Head and Neck Cancer” to be April 7
Discovery by Vanderbilt-led group could lead to improved diabetes treatment
Vanderbilt investigators and colleagues around the country have made a major discovery that could lead to better ways to treat type 1 diabetes. Continue reading
Posted in News
Comments Off on Discovery by Vanderbilt-led group could lead to improved diabetes treatment
eStar stabilization survey continues
In January thousands of Vanderbilt University Medical Center colleagues completed a survey administered by Epic, which provided valuable insight into users’ experiences so far with eStar. Continue reading
Posted in News
Comments Off on eStar stabilization survey continues
Dysregulated Response of Follicular Helper T cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients
Production of neutralizing antibodies against hepatitis B surface antigen (HBsAg) is dysregulated in patients with persistent hepatitis V virus (HBV) infection. We investigated mechanisms by which this immune response to the virus is disrupted and whet… Continue reading
Posted in News
Comments Off on Dysregulated Response of Follicular Helper T cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients
Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll Like Receptor 3 in Hepatocytes
Hepatitis C virus (HCV) infections often persist lifelong. We have identified a novel viral immune evasion mechanism based on the secretion of viral double stranded RNA from infected cells in extracellular vesicles. Thereby the virus is less efficientl… Continue reading
Posted in News
Comments Off on Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll Like Receptor 3 in Hepatocytes
Baseline Factors Associated with Improvements in Decompensated Cirrhosis After Direct-acting Antiviral Therapy for HCV Infection
Treatment with direct-acting antiviral (DAA) agents can reduce model for end-stage liver disease and Child-Pugh-Turcotte (CPT) scores in patients with decompensated cirrhosis caused by hepatitis C virus (HCV). However, many of these patients still die … Continue reading
Posted in News
Comments Off on Baseline Factors Associated with Improvements in Decompensated Cirrhosis After Direct-acting Antiviral Therapy for HCV Infection
Information for Authors and Readers
Gastroenterology is the premiere journal in the field of gastrointestinal disease and is led by an internationally renowned board of editors. As the official journal of the AGA Institute, Gastroenterology delivers up-to-date and authoritative coverag… Continue reading
Posted in News
Comments Off on Information for Authors and Readers